- Home
- AES vs RGEN Comparison
AES vs RGEN Comparison
Compare AES & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AES
- RGEN
- Stock Information
- Founded
- AES 1981
- RGEN 1981
- Country
- AES United States
- RGEN United States
- Employees
- AES N/A
- RGEN N/A
- Industry
- AES Electric Utilities: Central
- RGEN Medical/Dental Instruments
- Sector
- AES Utilities
- RGEN Health Care
- Exchange
- AES Nasdaq
- RGEN Nasdaq
- Market Cap
- AES 7.1B
- RGEN 8.0B
- IPO Year
- AES 1991
- RGEN N/A
- Fundamental
- Price
- AES $10.00
- RGEN $118.15
- Analyst Decision
- AES Buy
- RGEN Buy
- Analyst Count
- AES 7
- RGEN 12
- Target Price
- AES $12.71
- RGEN $172.67
- AVG Volume (30 Days)
- AES 19.8M
- RGEN 819.3K
- Earning Date
- AES 05-01-2025
- RGEN 04-29-2025
- Dividend Yield
- AES 7.04%
- RGEN N/A
- EPS Growth
- AES 146.43
- RGEN N/A
- EPS
- AES 1.83
- RGEN N/A
- Revenue
- AES $12,119,000,000.00
- RGEN $650,429,000.00
- Revenue This Year
- AES $4.10
- RGEN $13.93
- Revenue Next Year
- AES $2.95
- RGEN $14.35
- P/E Ratio
- AES $5.47
- RGEN N/A
- Revenue Growth
- AES N/A
- RGEN 4.88
- 52 Week Low
- AES $9.46
- RGEN $102.97
- 52 Week High
- AES $22.21
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- AES 40.15
- RGEN 38.20
- Support Level
- AES $9.46
- RGEN $120.11
- Resistance Level
- AES $12.67
- RGEN $129.42
- Average True Range (ATR)
- AES 0.51
- RGEN 6.02
- MACD
- AES -0.16
- RGEN -1.20
- Stochastic Oscillator
- AES 16.67
- RGEN 5.96
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.